(Total Views: 526)
Posted On: 02/20/2020 5:34:49 PM
Post# of 148936
Re: SouthernGold #18811
VANCOUVER, Washington, Feb. 20, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company"
, a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today an interview with president and chief executive officer Nader Pourhassan, Ph.D., will air on The RedChip Money Report television program. The interview will air Sunday, February 23, at 3 p.m. local time on Bloomberg International, available in 100+ million homes across Europe.
In the exclusive interview, Dr. Pourhassan discusses the Company’s pipeline of innovative treatments for multiple indications, as well as the anticipated upcoming commercial launch of its HIV combination therapy.
To view the interview segment, please visit: https://youtu.be/wQUEoQlq59Y
, a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today an interview with president and chief executive officer Nader Pourhassan, Ph.D., will air on The RedChip Money Report television program. The interview will air Sunday, February 23, at 3 p.m. local time on Bloomberg International, available in 100+ million homes across Europe. In the exclusive interview, Dr. Pourhassan discusses the Company’s pipeline of innovative treatments for multiple indications, as well as the anticipated upcoming commercial launch of its HIV combination therapy.
To view the interview segment, please visit: https://youtu.be/wQUEoQlq59Y
(0)
(0)Scroll down for more posts ▼
